by Chantelle Janse van Rensburg | Nov 29, 2018 | Featured, Journals, News
CIPLA LAUNCHES NEW TRIPLE-COMBINATION ANTIRETROVIRAL DRUG, REYDIN Ahead of World Aids Day and as part of its continued commitment to ensuring access to quality, affordable antiretrovirals (ARV), Cipla is launching its new triple-combination ARV treatment for HIV in...
by Chantelle Janse van Rensburg | Nov 28, 2018 | News, PNT, SAFP, SAPA, SAPJ
ACITOP PACKAGING GETS A FACELIFT The HSV-1 herpes virus affects 67% of people globally under the age of 50 1. This herpes virus causes the formation of a cold sore or fever blister 1,2. The virus is highly contagious especially when symptoms are present however, can...
by Chantelle Janse van Rensburg | Nov 28, 2018 | News, PNT, SAFP, SAPA, SAPJ
Lansinoh® 2-in-1 Double Electric Breast Pump & Lansinoh® Breastmilk Storage Bags The ultimate choice for women who want comfort and flexibility when expressing milk, is the Lansinoh® 2-in-1 Double Electric Breast Pump which features 3 pumping styles and 8...
by Chantelle Janse van Rensburg | Nov 26, 2018 | Featured, JEMDSA, News, SAPJ
Empagliflozin proven to improve clinical outcomes in real world practice across a broad spectrum of cardiovascular risk Subsequent to the mandate by the US Food and Drug Administration (FDA) that all new glucose-lowering agents should be tested for...
by Chantelle Janse van Rensburg | Nov 26, 2018 | News
Aspen launches novel ARV Combination: Set to further improve treatment options Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of Emdolten®, a Dolutegravir-based triple combination anti-retroviral...
